ScopeSynnovis Analytics
Official name: Synnovis Analytics LLP
123 capabilities
Verified Oct 2026
One of 2,018 in United Kingdom
Send one structured enquiry and we chase the reply for you. No cold email, no chasing.
Details
Genetics Centre, 5th Floor Tower Wing, Guy's Hospital
Guy's Hospital SE1 9RT , United Kingdom
Guy's Hospital SE1 9RT , United Kingdom
Accreditation
Active
UKAS
8688
nhs.net
Prefer to enquire through us? Send an enquiry
Accreditation Details
Accreditation Body
UKAS
Number
8688
Status
ActiveAccreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official UKAS records.
Download Scope PDFOther locations
Synnovis Analytics
King's College Hospital
Synnovis Analytics
London
Synnovis Analytics
King’s College Hospital
Synnovis Analytics
London
Synnovis Analytics
London
Synnovis Analytics
London
Synnovis Analytics
London
Synnovis Analytics
Denmark Hill
Synnovis Analytics
Guy's Hospital
Synnovis Analytics
9 King’s Head Yard
Synnovis Analytics
London
Synnovis Analytics
London
Synnovis Analytics
Denmark Hill
Test Capabilities (123)
| Standard Reference | Description | Category |
|---|---|---|
| MEASUREMENT | Measurement | Electrical |
| PML/RARα | PML/RARα | Food Safety Testing |
| RET | RET | Hematology |
| BCL6 | BCL6 | Histopathology / Cytology |
| Detection of | Detection of : | Manual Indirect | Immunology / Serology |
| Angelman Syndrome R47 | Angelman Syndrome R47 | Molecular Diagnostics / PCR |
| BCRABL quantitation (for CML p210 only) | BCRABL quantitation (for CML p210 only) | Molecular Diagnostics / PCR |
| Core Binding Factor translocations QPCR | Core Binding Factor translocations QPCR | Molecular Diagnostics / PCR |
| Cystic Fibrosis R184 and R185 | Cystic Fibrosis R184 and R185 | Molecular Diagnostics / PCR |
| Cystic fibrosis (CFTR common variants) Elucigene | Cystic fibrosis (CFTR common variants) Elucigene | Molecular Diagnostics / PCR |
| Detection of CALR mutation | Detection of CALR mutation | Molecular Diagnostics / PCR |
| Detection of PMLRARA fusion transcripts | Detection of PMLRARA fusion transcripts | Molecular Diagnostics / PCR |
| Detection of Single | Detection of Single | Molecular Diagnostics / PCR |
| Detection of nucleic acid sequence variants and/or copy number changes for the purpose of clinical diagnosis measurement | Detection of nucleic acid sequence variants and/or copy number changes for the purpose of clinical diagnosis measurement | Molecular Diagnostics / PCR |
| Detection of pathogenic gene variants for inherited genetic disorders for the purpose of clinical diagnosis | Detection of pathogenic gene variants for inherited genetic disorders for the purpose of clinical diagnosis | Molecular Diagnostics / PCR |
| Detection of pathogenic gene variants for inherited genetic disorders for the purpose of clinical diagnosis measurement | Detection of pathogenic gene variants for inherited genetic disorders for the purpose of clinical diagnosis measurement | Molecular Diagnostics / PCR |
| Duchenne/Becker muscular dystrophy (dystrophin) R73 | Duchenne/Becker muscular dystrophy (dystrophin) R73 | Molecular Diagnostics / PCR |
| ETV6 | ETV6::RUNX1 | Molecular Diagnostics / PCR |
| Familial hypercholesterolaemia R134 | Familial hypercholesterolaemia R134 | Molecular Diagnostics / PCR |
| Fragile X syndrome (FMR1) | Fragile X syndrome (FMR1) | Molecular Diagnostics / PCR |
| Huntington disease (HTT) | Huntington disease (HTT) | Molecular Diagnostics / PCR |
| IGH | IGH::BCL2-Genfusion | Molecular Diagnostics / PCR |
| JAK2 V617F Mutational status measurement | JAK2 V617F Mutational status measurement | Molecular Diagnostics / PCR |
| JAK2 V617F quantification and determination of allelic burden measurement | JAK2 V617F quantification and determination of allelic burden measurement | Molecular Diagnostics / PCR |
| KMT2A/AFF1 | KMT2A/AFF1 | Molecular Diagnostics / PCR |
| MET | MET | Molecular Diagnostics / PCR |
| MPL exon 10 and/or JAK2 exon 12 mutational status | MPL exon 10 and/or JAK2 exon 12 mutational status | Molecular Diagnostics / PCR |
| MRD testing | MRD testing | Molecular Diagnostics / PCR |
| MYB | MYB::GATA1 (OMIM #189990) | Molecular Diagnostics / PCR |
| MYC | MYC:IGH fusion | VP2000, Manual/BioView | Molecular Diagnostics / PCR |
| Molecular Genetics | Molecular Genetics | Molecular Diagnostics / PCR |
| Next Generation Sequencing | Next generation sequencing | Molecular Diagnostics / PCR |
| Next generation sequencing (NGS) | Next generation sequencing (NGS) | Molecular Diagnostics / PCR |
| Nucleophohosmin Mutation detection | Nucleophohosmin Mutation detection | Molecular Diagnostics / PCR |
| Nucleotide Variants (SNVs) and Indels (insertions/deletions) within genes covered by the pan cancer panel | Nucleotide Variants (SNVs) and Indels (insertions/deletions) within genes covered by the pan cancer panel | Molecular Diagnostics / PCR |
| PGD | PGD | Molecular Diagnostics / PCR |
| Prader-Willi Syndrome R48 | Prader-Willi Syndrome R48 | Molecular Diagnostics / PCR |
| RUNX1/RUNX1T1 | RUNX1/RUNX1T1 | Molecular Diagnostics / PCR |
| Rare diseases measurement | Rare diseases measurement | Molecular Diagnostics / PCR |
| Sickle cell anaemia [HBB] measurement | Sickle cell anaemia [HBB] measurement | Molecular Diagnostics / PCR |
| Whole Genome Sequencing | Whole Genome Sequencing | Molecular Diagnostics / PCR |
| ALK | ALK | Other |
| Alpha6 integrin | Alpha6 integrin | Other |
| Analysis and reporting of the NGS outputs from MSK- ACCESS | Analysis and reporting of the NGS outputs from MSK- ACCESS | Other |
| Analysis and reporting of the NGS outputs measurement | Analysis and reporting of the NGS outputs measurement | Other |
| Analysis of CD138 cell separation: CKS1B/CDKN2C | Analysis of CD138 cell separation: CKS1B/CDKN2C | Other |
| Analysis of Chronic lymphocytic leukaemia genes: TP53/ATM | Analysis of Chronic lymphocytic leukaemia genes: TP53/ATM | Other |
| Analysis of Haematological malignancies caused by mutations within genes : Lymphoma probes: IGH/MYC IGH/CCND1 IGH/BCL2 IGH ALK BCL6 IGH/MALT1 BIRC3(API2)/MALT1 MYC | Analysis of Haematological malignancies caused by mutations within genes: BCR/ABL | Other |
| Analysis of the following genes: SS18 (SYT) | Analysis of the following genes: SS18 (SYT) | Other |
| Aneuploidy detection | Aneuploidy detection | Other |
| Anlaysis and reporting of the OncoDEEP NGS panel | Anlaysis and reporting of the OncoDEEP NGS panel | Other |
| BIRC3(API2)/MALT1 | BIRC3(API2)/MALT1 | Other |
| Beta4 integrin (CD104) | Beta4 integrin (CD104) | Other |
| CBFβ | CBFβ | Other |
| CHOP (DDIT3) | CHOP (DDIT3) | Other |
| Cancer genetics | Cancer genetics | Other |
| Chromosome 8 alpha satellite | Chromosome 8 alpha satellite | Other |
| Chromosome breakage studies measurement | Chromosome breakage studies measurement | Other |
| Chromosome rearrangement | Chromosome rearrangement | Other |
| Copy number variants (CNVs) | Copy number variants (CNVs) | Other |
| D20S108 | D20S108 | Other |
| D5S23, D5S721/CEP9/CEP15 | D5S23, D5S721/CEP9/CEP15 | Other |
| D7S486/CEP7 | D7S486/CEP7 | Other |
| DIRECT Test (confirmation of Whole Exome research results e.g. DDD project – varied genes) | DIRECT Test (confirmation of Whole Exome research results e.g. DDD project – varied genes) | Other |
| DLEU/13q34/CEP12 | DLEU/13q34/CEP12 | Other |
| DLEU/LAMP/CEP12 measurement | DLEU/LAMP/CEP12 measurement | Other |
| Desmoplakin 1 | Desmoplakin 1 | Other |
| Developmental disorder genetics | Developmental disorder genetics | Other |
| EGR1/D5S23, D5S721 | EGR1/D5S23, D5S721 | Other |
| ETV6/RUNX1 | ETV6/RUNX1 | Other |
| EVI | EVI | Other |
| EWSR1 | EWSR1 | Other |
| Extraction of DNA/RNA | Extraction of DNA/RNA | Other |
| FGFR1 | FGFR1 | Other |
| FIP1L1-PDGFRA | FIP1L1-PDGFRA | Other |
| FOXO1A (FKHR) | FOXO1A (FKHR) | Other |
| FUS | FUS | Other |
| Fanconi anaemia R229 | Fanconi anaemia R229 | Other |
| Genome-wide copy number variation | Genome-wide copy number variation | Other |
| HER2 | HER2 | Other |
| IGH/BCL2 | IGH/BCL2 | Other |
| IGH/CCND1 | IGH/CCND1 | Other |
| IGH/CCND3 | IGH/CCND3 | Other |
| IGH/FGFR3 | IGH/FGFR3 | Other |
| IGH/MAF | IGH/MAF | Other |
| IGH/MAFB | IGH/MAFB | Other |
| IGH/MALT1 | IGH/MALT1 | Other |
| IGH/MYC | IGH/MYC | Other |
| Immunodermatology | Immunodermatology | Other |
| KMT2A (MLL) | KMT2A (MLL) | Other |
| Karyotype | Karyotype | Other |
| Keratin 10 | Keratin 10 | Other |
| Keratin 14 | Keratin 14 | Other |
| Keratin 16 | Keratin 16 | Other |
| Keratin 5 | Keratin 5 | Other |
| M7.2 measurement | M7.2 measurement | Other |
| MAML2 | MAML2 | Other |
| Mapping of the following antigens: Laminin 5 (Laminin-332) | Mapping of the following antigens: Laminin 5 (Laminin-332) | Other |
| Maternal cell contamination measurement | Maternal cell contamination measurement | Other |
| Melanoma (BRAF exon 15) | Melanoma (BRAF exon 15) | Other |
| Non-specific global chromosome analysis for disease types: Acute myeloid leukaemia (AML) Acute lymphoblastic leukaemia (or lymphoma) (ALL) Chronic myeloid leukaemia (CML) Myelodysplastic syndromes (MDS) Myeloproliferative neoplasms (MPN) Non-Hodgkin’s lymphoma with bone marrow involvement | Non-specific global chromosome analysis for disease types: Acute myeloid leukaemia (AML) Acute lymphoblastic leukaemia (or lymphoma) (ALL) Chronic myeloid leukaemia (CML) Myelodysplastic syndromes (MDS) Myeloproliferative neoplasms (MPN) Non-Hodgkin’s lymphoma with bone marrow involvement | Other |
| PDGFRβ | PDGFRβ | Other |
| Plakophilin-1 measurement | Plakophilin-1 measurement | Other |
| Plectin C terminal | Plectin C terminal | Other |
| Plectin N terminal | Plectin N terminal | Other |
| Prenatal and reproductive genetics | Prenatal and reproductive genetics | Other |
| Processing of peripheral blood specimens to plasma and buffy coat | Processing of peripheral blood specimens to plasma and buffy coat | Other |
| Processing of transiently stabilised fresh cytological specimens to nucleic acids | Processing of transiently stabilised fresh cytological specimens to nucleic acids | Other |
| Purification and concentration | Purification and concentration | Other |
| R184/R185 | R184/R185 | Other |
| RARα | RARα | Other |
| ROS1 | ROS1 | Other |
| Structural variants (STR) | Structural variants (STR) | Other |
| TCF3(E2A) measurement | TCF3(E2A) measurement | Other |
| TP53/ATM | TP53/ATM | Other |
| Type IV collagen | Type IV collagen | Other |
| Type VII collagen | Type VII collagen | Other |
| Type XVII collagen | Type XVII collagen | Other |
| Unbalanced products from chromosome rearrangements (PGT-SR) measurement | Unbalanced products from chromosome rearrangements (PGT-SR) measurement | Other |
| Uniparental disomy of chromosomes 7, 14, 15 | Uniparental disomy of chromosomes 7, 14, 15 | Other |
| Vysis Melanoma panel | Vysis Melanoma panel | Other |
| Vysis UroVysion FISH panel | Vysis UroVysion FISH panel | Other |
| X inactivation R111 | X inactivation R111 | Other |
Send an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.